Article
Evaluation of MicroScan WalkAway and Vitek 2 for determination of the susceptibility of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates to cefepime, cefotaxime and ceftazidime.
The Journal of antimicrobial chemotherapy - 1 Oct 2013
Jang Woori, Park Yeon-Joon, Park Kang Gyun, Yu Jinkyung
Abstract excerpt
OBJECTIVES: The aim of this study was to evaluate the accuracies of these automated susceptibility test systems with cefepime, cefotaxime and ceftazidime using the new CLSI and EUCAST guidelines in extended-spectrum β-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae. METHODS: A total of 220 ESBL-producing clinical isolates were collected from 12 hospitals in Korea. Susceptibility testing for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.